Table 1 Demographic data and clinical parameters
|  |  | DWS− A | DWS− Pc | DWS+ A | DWS+ Pc |
|---|---|---|---|---|---|
Number of individuals, n | Â | 10 | 7 | 9 | 4 |
Male, n (%) | Â | 3 (30Â %) | 2 (28.6Â %) | 4 (44.4Â %) | 1 (25Â %) |
Age in years, median (range) |  | 33 (18–50) | 27 (18–50) | 30 (16–47) | 18 (16–46) |
Days after symptom onset, median (range) |  | 4 (1–8) | 294.5 (133–323) | 6 (3–9) | 268 (128–309) |
Type of infection, n (%) | Primary | 3 (30Â %) | 3 (42.9Â %) | 0 (0Â %) | 0 (0Â %) |
| Â | Secondary | 7 (70Â %) | 4 (57.1Â %) | 9 (100Â %) | 4 (100Â %) |
Serotype, n (%) | DENV1 | 2 (20Â %) | NA | 3 (33.3Â %) | NA |
| Â | DENV2 | 5 (50Â %) | NA | 5 (55.6Â %) | NA |
| Â | Unknown | 3 (30Â %) | NA | 1 (11.1Â %) | NA |
Hemoglobin, mean (SD) | Â | 14.2 (1.5) | UD | 13.55 (2.0) | UD |
Platelets, mean (SD) | Â | 125.5 (78.0) | UD | 68.8 (34.7) | UD |